Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects

NCT02263976 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BEA 2180 BR
DRUG: Placebo
DEVICE: Respimat® A 4
DRUG: Methacholine Chloride
DRUG: Spiriva

Sponsor

Boehringer Ingelheim